Comparing Envoy Medical (NASDAQ:COCH) & Coloplast A/S (OTCMKTS:CLPBY)

Envoy Medical (NASDAQ:COCH) and Coloplast A/S (OTCMKTS:CLPBY) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation and earnings.

Profitability

This table compares Envoy Medical and Coloplast A/S’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	N/A	N/A	-100.39%
Coloplast A/S	19.48%	43.30%	11.89%

Valuation and Earnings

This table compares Envoy Medical and Coloplast A/S’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$320,000.00	309.93	-$29.91 million	N/A	N/A
Coloplast A/S	$3.58 billion	N/A	$685.88 million	$0.33	39.30

Coloplast A/S has higher revenue and earnings than Envoy Medical.

Risk and Volatility

Envoy Medical has a beta of 2.68, meaning that its share price is 168% more volatile than the S&P 500. Comparatively, Coloplast A/S has a beta of -0.04, meaning that its share price is 104% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Envoy Medical and Coloplast A/S, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	2	0	3.00
Coloplast A/S	1	3	1	0	2.00

Envoy Medical currently has a consensus target price of $6.00, indicating a potential upside of 18.58%. Given Envoy Medical’s stronger consensus rating and higher probable upside, research analysts plainly believe Envoy Medical is more favorable than Coloplast A/S.

Institutional and Insider Ownership

8.6% of Envoy Medical shares are held by institutional investors. 0.7% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Envoy Medical beats Coloplast A/S on 6 of the 11 factors compared between the two stocks.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.